Log In
Print
BCIQ
Print
Print this Print this
 

Twynsta (telmisartan/amlodipine)

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionCombination of telmisartan, a small molecule angiotensin II receptor, and amlodipine, a calcium channel blocker
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTo treat hypertension alone or in combination with other anti-hypertensive agents, or as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals; Treat hypertension
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today